RPRX, far better to be silent than 2x
Really, there is just NO way the 2x number is a good representation of the data.
To start with, they could just release the %/arm (is 60/30/30 right?) and we could all decide for ourselves if the 2x is the right way to look at it.
It's really simple, if a small bio ofuscates data, it is bad, period.
The problem though is not the drop out number, but the fact RPRX is keeping mum. Skeletons.
Question. Of the original trial design what percentage made it to the finish in the treatment arms? 17 out of 50 or something?
Market Data 
Markets 
AI
